Motac Neuroscience

Services

Bespoke preclinical neuroscience studies supporting the development of new treatments for central nervous system disorders.
Histological section of brain tissue observed under a microscope for the study of central nervous system disease models.

Preclinical CNS Disease Models

Disease-relevant rodent and non-human primate (NHP) models of movement disorders, proteinopathies, cognitive disorders and spinal cord injury, supported by behavioural, functional and post-mortem endpoints.
X-ray profile of a skull demonstrating stereotactic neurosurgery and in vivo methodologies by Motac Neuroscience.

Stereotactic Neurosurgery & In Vivo Methodologies

Precision stereotactic neurosurgery, intracerebral delivery, PK/PD studies, brain microdialysis and chronic in vivo calcium imaging in rodents, pigs and non-human primates (NHP).
Detailed neurohistological analysis of a brain section under a microscope with purple staining for biomarker evaluation.

Neurohistology, Neurochemistry & Biomarker Analysis

Integrated neurohistology, immunohistochemistry, stereology, neurochemistry, neurobiochemistry and ultrasensitive biomarker analysis in biofluids and tissues.
Researcher wearing green gloves holding a microscope slide with a brain tissue sample labeled Motac Neuroscience.

CORE CAPABILITIES

Integrated Preclinical Neuroscience Expertise

Motac Neuroscience designs and conducts bespoke preclinical studies for pharmaceutical and biotechnology companies developing new treatments for central nervous system disorders.

Our scientists combine internationally recognised expertise in neuroanatomy, neurophysiology, neuropharmacology and neuropsychology with flexible study design, translational disease models and expert data interpretation.

CNS Disease Models & Functional Assessment

Disease-relevant preclinical models of Parkinson’s disease, multiple system atrophy, dementia with Lewy bodies, Alzheimer’s disease, progressive supranuclear palsy, Huntington’s disease, amyotrophic lateral sclerosis, cognitive disorders and spinal cord injury. Studies can integrate motor performance, behavioural assessment, CANTAB-based cognitive testing, sleep, vigilance and attention endpoints.

Stereotactic Neurosurgery & In Vivo Methodologies

Advanced stereotactic neurosurgery in rodents, pigs and non-human primates (NHP), including intracerebral delivery, brain microdialysis, PK/PD studies and chronic in vivo calcium imaging.

Neurohistology, Neurochemistry & Biomarker Analysis

Integrated behavioural, neurochemical and post-mortem endpoints, including neurohistology, immunohistochemistry, stereology, neurochemistry, neurobiochemistry, HPLC analysis and quantitative biomarker measurement.

THERAPEUTIC FOCUS

Key Application Areas

Disease-relevant preclinical models and translational endpoints across major movement disorders, proteinopathies, cognitive disorders and spinal cord injuries.

Parkinson's Disease &
Movement Disorders

Rodent and non-human primate (NHP) models for Parkinson's disease, dyskinesia, motor fluctuations, tremor, neurodegeneration, neuroprotection and neurorestoration.

Synucleinopathies

Alpha-synuclein models for Parkinson's disease, dementia with Lewy bodies and multiple system atrophy, including seeding and preformed fibril approaches.

Alzheimer's Disease & Tauopathies

Preclinical models of Alzheimer's disease and tauopathies, including amyloid-beta-induced memory impairment and tau seeding studies.

Cognitive Disorders & Neuropsychology

Translational cognitive assessment using aged macaque and scopolamine models, CANTAB-based testing, object retrieval tasks, memory and attention endpoints.

ALS & Spinal Cord Injury

Preclinical models and functional endpoints for amyotrophic lateral sclerosis and spinal cord injury, including motor, kinematic and anatomical assessment.

Huntington's Disease & Other Proteinopathies

Expertise in Huntington's disease and other proteinopathies, supported by tailored behavioural, biochemical, neurochemical and histopathological read-outs.

Advance your preclinical programme

Discuss your next preclinical study with our scientific team and accelerate its progression towards proof of concept.

Défiler vers le haut